Gene · 2280
Papers1,820
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,820
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A robust dual gene ON-OFF toggle directed by two independent promoter-degron pairs. | J Cell Sci | 2023 | 36995025 | PubTator, text mining | PubMed |
| Forward Genetics-Based Approaches to Understanding the Systems Biology and Molecular Mechanisms of Epilepsy. | Int J Mol Sci | 2023 | 36982355 | PubTator, text mining | PubMed |
| The Peptidyl-Prolyl cis-trans isomerase, Pin1, associates with Protein Kinase C θ via a critical Phospho-Thr-Pro motif in the V3 regulatory domain. | Front Immunol | 2023 | 36969236 | PubTator, text mining | PubMed |
| The function and mechanisms of action of circular RNAs in Urologic Cancer. | Mol Cancer | 2023 | 36966306 | PubTator, text mining | PubMed |
| Protein sociology of ProA, Mip and other secreted virulence factors at the Legionella pneumophila surface. | Front Cell Infect Microbiol | 2023 | 36936764 | PubTator, text mining | PubMed |
| Regulation of mTORC1 by the Rag GTPases. | Biochem Soc Trans | 2023 | 36929165 | PubTator, text mining | PubMed |
| Adult spinal cord tissue transplantation combined with local tacrolimus sustained-release collagen hydrogel promotes complete spinal cord injury repair. | Cell Prolif | 2023 | 36916024 | PubTator, text mining | PubMed |
| Antiviral Effect of Ginsenosides rk1 against Influenza a Virus Infection by Targeting the Hemagglutinin 1-Mediated Virus Attachment. | Int J Mol Sci | 2023 | 36902398 | PubTator, text mining | PubMed |
| Autophagy-Related Gene WD Repeat Domain 45B Promotes Tumor Proliferation and Migration of Hepatocellular Carcinoma through the Akt/mTOR Signaling Pathway. | Diagnostics (Basel) | 2023 | 36900050 | PubTator, text mining | PubMed |
| Transcription shapes 3D chromatin organization by interacting with loop extrusion. | Proc Natl Acad Sci U S A | 2023 | 36897969 | PubTator, text mining | PubMed |
| Therapeutic potency of compound RMY-205 for pulmonary fibrosis induced by SARS-CoV-2 nucleocapsid protein. | Cell Chem Biol | 2023 | 36889311 | PubTator, text mining | PubMed |
| FPR1 is essential for rapamycin-induced lifespan extension in Saccharomyces cerevisiae. | Biochem Biophys Res Commun | 2023 | 36857903 | PubTator, text mining | PubMed |
| Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders. | Biomedicines | 2023 | 36830793 | PubTator, text mining | PubMed |
| E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology. | J Med Chem | 2023 | 36821822 | PubTator, text mining | PubMed |
| Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application. | Mol Cancer | 2023 | 36810071 | PubTator, text mining | PubMed |
| Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy. | Brain | 2023 | 36806388 | PubTator, text mining | PubMed |
| In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease. | SLAS Technol | 2023 | 36804177 | PubTator, text mining | PubMed |
| Coronary microvascular dysfunction: A review of recent progress and clinical implications. | Front Cardiovasc Med | 2023 | 36776251 | PubTator, text mining | PubMed |
| Recent Update and Drug Target in Molecular and Pharmacological Insights into Autophagy Modulation in Cancer Treatment and Future Progress. | Cells | 2023 | 36766800 | PubTator, text mining | PubMed |
| Histopathological efficacy of tacrolimus in an experimental head trauma study. | Ulus Travma Acil Cerrahi Derg | 2023 | 36748776 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2280/papers?page=10